retatrutide peptide mexico Retatrutida 10 mg México | Triple Agonista con COA Buy Reta 30mg | Triple

GLP-1s dont look addictive in the same way

By suppressing hunger and promoting a sense of fullness, these medications support sustainable weight loss without extreme diets or exercise routines

Clinical Trial Results Clinical trials report weight loss averages around 15-20%

GLP-1 drugs have become one of the most closely watched areas in Koreas drug market since Novo Nordisks Wegovy (semaglutide) launched in October 2024 and Mounjaro entered the market in 2025

In the Wegovy-pill clinical trial, 18% of people who received the medication discontinued the treatment, which was less than the 26% rate in the placebo group

This is also shown to support Diabetic patients as well as minimize nerve pain